Thomas C Kwee1, Robert M Kwee, Abass Alavi. 1. Department of Radiology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. thomaskwee@gmail.com
Abstract
PURPOSE: The aim of this study was to systematically review and metaanalyze published data on the diagnostic performance of (18)F-fluoro-2-deoxyglucose positron emission tomography (FDG-PET) in detecting prosthetic hip or knee joint infection. METHODS: A systematic search for relevant studies was performed of the PubMed/MEDLINE and Embase databases. Two reviewers independently assessed the methodological quality of each study. A metaanalysis of the reported sensitivity and specificity of each study was performed. Subgroup analyses were performed if results of individual studies were heterogeneous. RESULTS: The inclusion criteria were met by 11 studies; there was a total sample size of 635 prostheses. Overall, the studies had good methodological quality. Pooled sensitivity and specificity of FDG-PET for the detection of prosthetic hip or knee joint infection were 82.1% (95%CI = 68.0-90.8%) and 86.6% (95%CI = 79.7-91.4%), respectively. Heterogeneity among the results of individual studies was present (I (2) = 68.8%). Diagnostic performance was influenced by type of joint prostheses (hip prostheses vs. knee prostheses) and type of reconstruction method used (filtered back vs. iterative) (p = 0.0164 and p = 0.0235, respectively). CONCLUSION: In this metaanalysis, overall diagnostic performance of FDG-PET was moderate to high. Caution is warranted, however, because results of individual studies were heterogeneous and could not be fully explored. Future studies should further explore potential causes of heterogeneity and validate the use of FDG-PET for diagnosing prosthetic joint infection.
PURPOSE: The aim of this study was to systematically review and metaanalyze published data on the diagnostic performance of (18)F-fluoro-2-deoxyglucose positron emission tomography (FDG-PET) in detecting prosthetic hip or knee joint infection. METHODS: A systematic search for relevant studies was performed of the PubMed/MEDLINE and Embase databases. Two reviewers independently assessed the methodological quality of each study. A metaanalysis of the reported sensitivity and specificity of each study was performed. Subgroup analyses were performed if results of individual studies were heterogeneous. RESULTS: The inclusion criteria were met by 11 studies; there was a total sample size of 635 prostheses. Overall, the studies had good methodological quality. Pooled sensitivity and specificity of FDG-PET for the detection of prosthetic hip or knee joint infection were 82.1% (95%CI = 68.0-90.8%) and 86.6% (95%CI = 79.7-91.4%), respectively. Heterogeneity among the results of individual studies was present (I (2) = 68.8%). Diagnostic performance was influenced by type of joint prostheses (hip prostheses vs. knee prostheses) and type of reconstruction method used (filtered back vs. iterative) (p = 0.0164 and p = 0.0235, respectively). CONCLUSION: In this metaanalysis, overall diagnostic performance of FDG-PET was moderate to high. Caution is warranted, however, because results of individual studies were heterogeneous and could not be fully explored. Future studies should further explore potential causes of heterogeneity and validate the use of FDG-PET for diagnosing prosthetic joint infection.
Authors: Afina S Glas; Jeroen G Lijmer; Martin H Prins; Gouke J Bonsel; Patrick M M Bossuyt Journal: J Clin Epidemiol Date: 2003-11 Impact factor: 6.437
Authors: Stephen J Skehan; Jessica F White; John W Evans; David R Parry-Jones; Chandra K Solanki; James R Ballinger; Edwin R Chilvers; A Michael Peters Journal: J Nucl Med Date: 2003-01 Impact factor: 10.057
Authors: Katrin D M Stumpe; Hubert P Nötzli; Marco Zanetti; Ehab M Kamel; Thomas F Hany; Gerhard W Görres; Gustav K von Schulthess; Juerg Hodler Journal: Radiology Date: 2004-03-24 Impact factor: 11.105
Authors: Penny F Whiting; Marie E Weswood; Anne W S Rutjes; Johannes B Reitsma; Patrick N M Bossuyt; Jos Kleijnen Journal: BMC Med Res Methodol Date: 2006-03-06 Impact factor: 4.615
Authors: Vera Wenter; Jan-Phillip Müller; Nathalie L Albert; Sebastian Lehner; Wolfgang P Fendler; Peter Bartenstein; Clemens C Cyran; Jan Friederichs; Matthias Militz; Marcus Hacker; Sven Hungerer Journal: Eur J Nucl Med Mol Imaging Date: 2015-11-07 Impact factor: 9.236
Authors: Filip Gemmel; Hans Van den Wyngaert; Charito Love; M M Welling; Paul Gemmel; Christopher J Palestro Journal: Eur J Nucl Med Mol Imaging Date: 2012-02-24 Impact factor: 9.236
Authors: Thomas Falstie-Jensen; J Lange; H Daugaard; M H Vendelbo; A K Sørensen; B Zerahn; J Ovesen; K Søballe; L C Gormsen Journal: Eur J Nucl Med Mol Imaging Date: 2019-07-11 Impact factor: 9.236
Authors: Albert Wu; Huaiyu Zheng; Jennifer Kraenzle; Ashley Biller; Carol D Vanover; Mary Proctor; Leslie Sherwood; Marlene Steffen; Chin Ng; Daniel J Mollura; Colleen B Jonsson Journal: ILAR J Date: 2012